Colitis Drug Development: 2018 Pipeline Analysis Report - ResearchAndMarkets.com

DUBLIN--()--The "2018 Colitis Drug Development - Pipeline Analysis Report" report has been added to ResearchAndMarkets.com's offering.

Over 40 companies and universities are focusing on developing treatment options for Colitis.

This report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials. Drugs under development directly and through combination with other drugs are also included.

Current status, developmental phase, participating companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Colitis pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key trends in Colitis pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.

Companies Mentioned

  • Affilogic
  • Ajinomoto Co Inc
  • Akebia Therapeutics
  • Apollo Endosurgery Inc
  • Brigham Young University Inc
  • Bristol-Myers Squibb Co
  • Concenter BioPharma Silkim Ltd
  • Conseil National de Rechereche en Sante (CNRS) du Senegal
  • Cosmo Pharmaceuticals NV
  • Crinos SpA
  • CSA Biotechnologies LLC
  • Dr. Falk Pharma GmbH
  • EA Pharma Co Ltd
  • enGene Inc
  • FairJourney Biologics
  • GeneFrontier Corp
  • Genfit SA
  • Hadasit Medical Research Services and Development Ltd
  • Immuron Ltd
  • James Cook University
  • Kissei Pharmaceutical Co Ltd
  • Koutif Therapeutics LLC
  • MorphoSys AG
  • Ogeda SA
  • Pfizer Inc
  • RDD Pharma Ltd
  • RIKEN
  • Riptide Bioscience Inc
  • Salix Pharmaceuticals Ltd
  • Saniona AB
  • Synovo GmbH
  • Tel Aviv University
  • TPCera Ltd
  • Vedanta Biosciences Inc
  • Vitality Biopharma Inc

Key Topics Covered

1 Table of Contents

2 Colitis Pipeline Analysis

3 Colitis - Company-wise Pipeline Analysis

4 Colitis R&D Pipeline Snapshots

5 Recent Developments in Colitis Pipeline

For more information about this report visit https://www.researchandmarkets.com/research/h4b8z9/colitis_drug?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Gastrointestinal Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Gastrointestinal Drugs